In this episode, Dennis Walker speaks with Dr. Jonathan Fields, an integrative medicine specialist who is currently petitioning the DEA to respect the ‘Right to Try Laws’ in relation to empowering terminally ill patients to legally access psilocybin therapy.
Core One Labs appears to be following in footsteps of Mind Cure, but that doesn’t mean the entire psychedelics industry is in trouble.
The family of Bob Marley and Silo Wellness have teamed up for the first line of commercial psilocybin mushrooms.
![MindMed Taking On The $30 BILLION Pain Relief Industry? [MMED / MNMD Expanding with Project Angie ]](https://psychedelicspotlight.com/wp-content/uploads/2022/06/maxresdefault-140-600x338.jpeg)
Project Angie: Can MindMed Disrupt the Pain Relief Industry? [MMED / MNMD Expanding Horizons]
Breaking NEWS: MindMed ( MNMD / MMED / MMQ ) launching a new flagship program called Angie to advance the development of psychedelics, including LSD and potentially penetrate the pain killer industry by treating pain conditions. MindMed is currently exploring two primary clinical indications for the treatment of pain:
MindMed will initiate a study of LSD in a severe pain indication. MMED is currently preparing a pre-IND briefing package for this Phase 2a Proof of Concept study. They plan to submit to the FDA in the second half of 2021.
( As a note, that means they could present this doc anywhere between July 1st and December 31st. So it is conceivable that this trial could start at the tail end of 2021, if this doc gets presented at the beginning of that period.)
The second indication that MindMed is evaluating is “the common, often debilitating, chronic pain syndrome”.
Link to the 1964 study testing the LSDs ability to treat pain in cancer patients, and it had dual surprising results
: file:///C:/Users/maria/Downloads/Study_of_Lysergic_Acid_Diethylamide_as_an.13.pdf
Link to the 2020 a study was published that had among its authors 2 prominent MindMed collaborators: Mattias Liechti and Kim Kuypers: https://journals.sagepub.com/doi/full…
Link to the 2017study: https://www.ncbi.nlm.nih.gov/pmc/arti…
Link to MindMed ( MMED / MNMD/ MMQ ) : https://mindmed.co/
Link to MindMed ‘ s Press Release on Project Angie : https://mindmed.co/news/press-release…
Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌
Instagram: @psychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
https://benzinga.grsm.io/jameshallifa…
https://benzinga.grsm.io/thepsychedel…
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#MindMed #MindMedStock #MNMD
We chat with Rebecca Martinez and Elan Hagens who are the Founders of Fruiting Bodies Collective.
This week in psychedelic business news: Wesana Health pivots strategy; Compass Pathways makes progress on anorexia; Completion launches psychedelic VR NFTs.
The Canadian Minister of Mental Health and Addictions met with members of the Oregon psilocybin program, a surprise move which may signify easing restrictions on psychedelics
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.
